A new radioimmunotherapy approach has been shown to successfully eliminate cancer stem cells (CSCs) in preclinical models of ovarian cancer, outperforming the current gold standard. This research, ...
Results from a Phase 1 clinical trial for a cancer therapy show the potential to kill colorectal tumors with less destruction of healthy tissue. Further research could lead to the use of this ...
A new radioimmunotherapy approach has the potential to cure human epidermal growth factor receptor 2 (HER2)-positive breast cancer, according to new research published in the November issue of The ...
Radioimmunotherapy might be useful as an initial and standalone treatment for follicular non-Hodgkin's lymphoma, according to a phase 2 study. The study, by Christian Scholz, MD, and colleagues from ...
Scientists have piggybacked antibodies onto radioactive payloads to deliver doses of radiation that selectively target and destroy microbial and HIV-infected cells. The experimental treatment -- ...
In 1984, Rita Lawrence’s local oncologist in Illinois delivered a diagnosis of lymphoma. It was the start of a difficult journey. After a year of chemotherapy, and two years of remission, the cancer ...
VANCOUVER, British Columbia — In patients with refractory or relapsed aggressive lymphoma, immunoradiation combined with high-dose chemotherapy is associated with better progression-free and overall ...
Prognostic Significance of Partial Tandem Duplications of the MLL Gene in Adult Patients 16 to 60 Years Old With Acute Myeloid Leukemia and Normal Cytogenetics: A Study of the Acute Myeloid Leukemia ...
Use of cytokines in the treatment of acute myelocytic leukemia: a critical review. The highest complete response rates (overall, approximately 50%) have been achieved in patients with B-cell ...
A major advance in cancer therapy—high dose radioimmunotherapy—resulted in long-term remission for persons with mantle cell lymphoma. This often-fatal form of Non-Hodgkin’s Lymphoma (NHL) has a mean ...
Pretargeted radioimmunotherapy (PRIT) combines antibody-mediated immunotherapy with targeted delivery of radioisotopes. It is a multi-step process, first the administration of a monoclonal antibody, ...
Reston, VA (April 30, 2026)--A new pretargeted radioimmunotherapy (PRIT) technique has been shown to be safe and effective in eradicating tumors from a preclinical colorectal cancer model. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results